Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.
- 1 November 1979
- journal article
- Vol. 38 (3) , 481-8
Abstract
Mycobacterium bovis, BCG, is known to be capable of either enhancing or suppressing various immune responses. Using a standard technique and number of organisms, some of the parameters predetermining whether enhancement or supression will occur have been investigated. Dead BCG given intravenously into mice caused an enhancement of the antibody response in vitro to sheep erythrocytes. In contrast, the same number of viable organisms caused suppression if given intravenously but enhancement if given subcutaneously. The inclusion of 25% or more killed organisms in an intravenous inoculum of fully viable organisms changed suppression to enhancement. Treatment of BCG infected mice with streptomycin lessened the suppression but did not change it to enhancement. The possible causes of suppression are discussed.This publication has 21 references indexed in Scilit:
- ACTIVE SUPPRESSION OF INVITRO REACTIVITY OF SPLEEN-CELLS AFTER BCG TREATMENT1978
- Bcg in Tumor ImmunotherapyPublished by Elsevier ,1978
- Activation of guinea pig macrophages by cell walls of Mycobacterium bovis, strain BCGCellular Immunology, 1976
- Activation of lymphoid cells by BCG in vitroCellular Immunology, 1975
- Antitrinitrophenyl (TNP) Plaque Assay. Primary Response of Balb/c Mice to Soluble and Particulate ImmunogenExperimental Biology and Medicine, 1969
- THE HOST RESPONSE TO CALMETTE-GUÉRIN BACILLUS INFECTION IN MICEThe Journal of Experimental Medicine, 1969
- FURTHER IMPROVEMENTS IN PLAQUE TECHNIQUE FOR DETECTING SINGLE ANTIBODY-FORMING CELLS1968
- PRIMARY IMMUNE RESPONSE IN CULTURES OF SPLEEN CELLSThe Lancet, 1967